Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study

Clinical trial NCT00630786 · COMPLETED

Trial details

NCT number: NCT00630786
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colon Cancer Colorectal Cancer Rectal Cancer Metastatic Colorectal Cancer Oncology

Start date: 2008-01-01
Primary completion: 2009-05-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.